collaborators

12 papers

q-bio.BM2026

Cross-Chirality Generalization by Axial Vectors for Hetero-Chiral Protein-Peptide Interaction Design

Ziyi Yang, Zitong Tian, Yinjun Jia +7

D-peptide binders targeting L-proteins have promising therapeutic potential. Despite rapid advances in machine learning-based target-conditioned peptide design, generating D-peptid…

cs.LG2026

MolEvolve: LLM-Guided Evolutionary Search for Interpretable Molecular Optimization

Xiangsen Chen, Ruilong Wu, Yanyan Lan +2

Despite deep learning's success in chemistry, its impact is hindered by a lack of interpretability and an inability to resolve activity cliffs, where minor structural nuances trigg…

cs.LG2025

Learning Protein-Ligand Binding in Hyperbolic Space

Jianhui Wang, Wenyu Zhu, Bowen Gao +4

Protein-ligand binding prediction is central to virtual screening and affinity ranking, two fundamental tasks in drug discovery. While recent retrieval-based methods embed ligands…

cs.LG2025

SDrug: Bridging Protein Sequence and 3D Structure in Contrastive Representation Learning for Virtual Screening

Bowei He, Bowen Gao, Yankai Chen +5

Virtual screening (VS) is an essential task in drug discovery, focusing on the identification of small-molecule ligands that bind to specific protein pockets. Existing deep learnin…

cs.LG2025

AANet: Virtual Screening under Structural Uncertainty via Alignment and Aggregation

Wenyu Zhu, Jianhui Wang, Bowen Gao +5

Virtual screening (VS) is a critical component of modern drug discovery, yet most existing methods--whether physics-based or deep learning-based--are developed around holo protein…

cs.LG2025

Coder as Editor: Code-driven Interpretable Molecular Optimization

Wenyu Zhu, Chengzhu Li, Xiaohe Tian +7

Molecular optimization is a central task in drug discovery that requires precise structural reasoning and domain knowledge. While large language models (LLMs) have shown promise in…